Resumen
Exocrine pancreatic cancer is one of the neoplasias with a worse prognosis, with conventional treatments having little impact on disease outcome. Research and genomic high-throughput technology is continuously expanding our knowledge of pancreas cancer biology. Characterization of genetic and epigenetic alterations in pancreatic tumors has allowed a better understanding of the progression model of the disease at the molecular level. The development of new therapeutic approaches with target-oriented agents is been tested in the preclinical and clinical settings. This review updates the current available data on pancreatic cancer molecular biology.
Idioma original | Inglés |
---|---|
Páginas (desde-hasta) | 306-312 |
Número de páginas | 7 |
Publicación | Clinical and Translational Oncology |
Volumen | 8 |
N.º | 5 |
DOI | |
Estado | Publicada - 2006 |
Publicado de forma externa | Sí |